Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2017

21.06.2016

A Review of Autoimmune Disease Hypotheses with Introduction of the “Nucleolus” Hypothesis

verfasst von: Wesley H. Brooks

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Numerous hypotheses have been proposed in order to explain the complexity of autoimmune diseases. These hypotheses provide frameworks towards understanding the relations between triggers, autoantigen development, symptoms, and demographics. However, testing and refining these hypotheses are difficult tasks since autoimmune diseases have a potentially overwhelming number of variables due to the influence on autoimmune diseases from environmental factors, genetics, and epigenetics. Typically, the hypotheses are narrow in scope, for example, explaining the diseases in terms of genetics without defining detailed roles for environmental factors or epigenetics. Here, we present a brief review of the major hypotheses of autoimmune diseases including a new one related to the consequences of abnormal nucleolar interactions with chromatin, the “nucleolus” hypothesis which was originally termed the “inactive X chromosome and nucleolus nexus” hypothesis. Indeed, the dynamic nucleolus can expand as part of a cellular stress response and potentially engulf portions of chromatin, leading to disruption of the chromatin. The inactive X chromosome (a.k.a. the Barr body) is particularly vulnerable due to its close proximity to the nucleolus. In addition, the polyamines, present at high levels in the nucleolus, are also suspected of contributing to the development of autoantigens.
Literatur
1.
Zurück zum Zitat Prineas JW, Parratt JDE (2012) Oligodendrocytes and the early multiple sclerosis lesion. Annals Neurol 72(1):18–31CrossRef Prineas JW, Parratt JDE (2012) Oligodendrocytes and the early multiple sclerosis lesion. Annals Neurol 72(1):18–31CrossRef
2.
Zurück zum Zitat Van Noort JM, Baker D, Amor S (2012) Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factors. CNS & Neurological Disorders - Drug Targets 11(5):556–69CrossRef Van Noort JM, Baker D, Amor S (2012) Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factors. CNS & Neurological Disorders - Drug Targets 11(5):556–69CrossRef
3.
Zurück zum Zitat Anaya JM (2012) Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmunity Rev 11(11):781–4CrossRef Anaya JM (2012) Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmunity Rev 11(11):781–4CrossRef
4.
Zurück zum Zitat Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G (2012) How does age at onset influence the outcome of autoimmune diseases? Autoimmune Diseases 2012(art251730):1–7CrossRef Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G (2012) How does age at onset influence the outcome of autoimmune diseases? Autoimmune Diseases 2012(art251730):1–7CrossRef
5.
Zurück zum Zitat Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmunity 34:J207–19CrossRef Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmunity 34:J207–19CrossRef
6.
Zurück zum Zitat Le Dantec C, Brooks WH, Renaudineau Y (2015) Epigenomic revolution in autoimmune diseases. World J Immunol 5(2):62–67CrossRef Le Dantec C, Brooks WH, Renaudineau Y (2015) Epigenomic revolution in autoimmune diseases. World J Immunol 5(2):62–67CrossRef
7.
Zurück zum Zitat Lu Q, Renaudineau Y, Cha S et al (2010) Epigenetics in autoimmune disorders: highlights of the 10th Sjögren’s Syndrome Symposium. Autoimmunity Rev 9(9):627–30CrossRef Lu Q, Renaudineau Y, Cha S et al (2010) Epigenetics in autoimmune disorders: highlights of the 10th Sjögren’s Syndrome Symposium. Autoimmunity Rev 9(9):627–30CrossRef
8.
Zurück zum Zitat Thabet Y, Canas F, Ghedira I, Youinou P, Mageed RA, Renaudineau Y (2012) Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link? J Autoimmunity 39(3):154–60CrossRef Thabet Y, Canas F, Ghedira I, Youinou P, Mageed RA, Renaudineau Y (2012) Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link? J Autoimmunity 39(3):154–60CrossRef
9.
Zurück zum Zitat Zhang Z, Zhang R (2015) Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy. Autoimmunity Rev 14(10):854–63CrossRef Zhang Z, Zhang R (2015) Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy. Autoimmunity Rev 14(10):854–63CrossRef
10.
Zurück zum Zitat Konsta OD, Le Dantec C, Brooks WH, Renaudineau Y (2015) Genetics and epigenetics of autoimmune diseases. eLS. John Wiley & Sons, Ltd, Chichester, pp.1–9. Konsta OD, Le Dantec C, Brooks WH, Renaudineau Y (2015) Genetics and epigenetics of autoimmune diseases. eLS. John Wiley & Sons, Ltd, Chichester, pp.1–9.
11.
Zurück zum Zitat Konsta OD, Le Dantec C, Charras A, Brooks WH, Arleevskaya MI, Bordron A, Renaudineau Y (2015) An in silico approach reveals associations between genetic and epigenetic factors within regulatory elements in B cells from primary Sjögren’s syndrome patients. Front Immunol 6:437PubMedPubMedCentralCrossRef Konsta OD, Le Dantec C, Charras A, Brooks WH, Arleevskaya MI, Bordron A, Renaudineau Y (2015) An in silico approach reveals associations between genetic and epigenetic factors within regulatory elements in B cells from primary Sjögren’s syndrome patients. Front Immunol 6:437PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Thabet Y, Le Dantec C, Ghedira I, Devauchelle V, Cornec D, Pers J-O, Renaudineau Y (2013) Epigenetic dysregulation in salivary glands from patients with primary Sjögren’s syndrome may be ascribed to infiltrating B cells. J Autoimmunity 41:175–81CrossRef Thabet Y, Le Dantec C, Ghedira I, Devauchelle V, Cornec D, Pers J-O, Renaudineau Y (2013) Epigenetic dysregulation in salivary glands from patients with primary Sjögren’s syndrome may be ascribed to infiltrating B cells. J Autoimmunity 41:175–81CrossRef
13.
Zurück zum Zitat Invernizzi P, Pasini S, Selmi C et al (2009) Female predominance and X chromosome defects in autoimmune diseases. J Autoimmunity 33(1):12–6CrossRef Invernizzi P, Pasini S, Selmi C et al (2009) Female predominance and X chromosome defects in autoimmune diseases. J Autoimmunity 33(1):12–6CrossRef
14.
Zurück zum Zitat Renaudineau Y, Beauvillard D, Padelli M, Brooks WH, Youinou P (2011) Epigenetic alterations and autoimmune disease. J Dev Orig Health Dis 2(5):258–64PubMedCrossRef Renaudineau Y, Beauvillard D, Padelli M, Brooks WH, Youinou P (2011) Epigenetic alterations and autoimmune disease. J Dev Orig Health Dis 2(5):258–64PubMedCrossRef
15.
Zurück zum Zitat Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y (2007) Epstein–Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108:567–577PubMedCrossRef Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y (2007) Epstein–Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108:567–577PubMedCrossRef
16.
Zurück zum Zitat Arleevskaya MI, Zabotin A, Gabdoulkhakova A, Filina J, Tsibulkin A (2016) A possible interconnection of cholesterol overloading and phagocytic activity of the monocytes in the prone to rheumatoid arthritis individuals. Lupus Open Access 1:112 Arleevskaya MI, Zabotin A, Gabdoulkhakova A, Filina J, Tsibulkin A (2016) A possible interconnection of cholesterol overloading and phagocytic activity of the monocytes in the prone to rheumatoid arthritis individuals. Lupus Open Access 1:112
17.
Zurück zum Zitat James JA, Harley JB, Scofield RH (2006) Epstein–Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 18:462–467PubMedCrossRef James JA, Harley JB, Scofield RH (2006) Epstein–Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 18:462–467PubMedCrossRef
18.
Zurück zum Zitat Christensen T (2006) The role of EBV in MS pathogenesis. Intl MS J 13:52–57 Christensen T (2006) The role of EBV in MS pathogenesis. Intl MS J 13:52–57
19.
Zurück zum Zitat Fox RI, Luppi M, Pisa P, Kang HI (1992) Potential role of Epstein-Barr virus in Sjogren’s syndrome and rheumatoid arthritis. J Rheumatol Suppl 32:18–24PubMed Fox RI, Luppi M, Pisa P, Kang HI (1992) Potential role of Epstein-Barr virus in Sjogren’s syndrome and rheumatoid arthritis. J Rheumatol Suppl 32:18–24PubMed
20.
Zurück zum Zitat Sibley JT, Lee JS, Decoteau WE (1984) Left-handed “Z” DNA antibodies in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 11:633–7PubMed Sibley JT, Lee JS, Decoteau WE (1984) Left-handed “Z” DNA antibodies in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 11:633–7PubMed
21.
Zurück zum Zitat Van Helden PD (1985) Potential Z-DNA-forming elements in serum DNA from human systemic lupus erythematosus. J Immunol 134:177–9PubMed Van Helden PD (1985) Potential Z-DNA-forming elements in serum DNA from human systemic lupus erythematosus. J Immunol 134:177–9PubMed
23.
Zurück zum Zitat Minota S, Jarour WN, Suzuki N et al (1991) Autoantibodies to nucleolin in systemic lupus erythematosus and other diseases. J Immunol 146:2249–52PubMed Minota S, Jarour WN, Suzuki N et al (1991) Autoantibodies to nucleolin in systemic lupus erythematosus and other diseases. J Immunol 146:2249–52PubMed
24.
Zurück zum Zitat Harley JB, Scofield RH, Reichlin M (1992) Anti-Ro in Sjogren’s syndrome and systemic lupus erythematosus. Rheum Dis Clin NA 18(2):337–58 Harley JB, Scofield RH, Reichlin M (1992) Anti-Ro in Sjogren’s syndrome and systemic lupus erythematosus. Rheum Dis Clin NA 18(2):337–58
25.
Zurück zum Zitat Renaudineau Y, Hillion S, Saraux A, Youinou P (2014) Autoanticorps dans les maladies systémiques. Traité des maladies et syndromes systémiques. Flammarion Medecine Sciences Ch 6:1–32 Renaudineau Y, Hillion S, Saraux A, Youinou P (2014) Autoanticorps dans les maladies systémiques. Traité des maladies et syndromes systémiques. Flammarion Medecine Sciences Ch 6:1–32
26.
Zurück zum Zitat Baka Z, Gyӧrgy B, Géher P, Buzás EI, Falus A, Nagy G (2012) Citrullination under physiological and pathological conditions. Joint Bone Spine 79:431–6PubMedCrossRef Baka Z, Gyӧrgy B, Géher P, Buzás EI, Falus A, Nagy G (2012) Citrullination under physiological and pathological conditions. Joint Bone Spine 79:431–6PubMedCrossRef
27.
Zurück zum Zitat Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A et al (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5:178ra40PubMedPubMedCentralCrossRef Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A et al (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5:178ra40PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Garaud S, Le Dantec C, Jousse-Joulin S, Hanrotel-Saliou C, Saraux A, Mageed RA, Youinou P, Renaudineau Y (2009) IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 182(9):5623–32PubMedCrossRef Garaud S, Le Dantec C, Jousse-Joulin S, Hanrotel-Saliou C, Saraux A, Mageed RA, Youinou P, Renaudineau Y (2009) IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 182(9):5623–32PubMedCrossRef
29.
Zurück zum Zitat Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya JM (2012) Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Diseases 2012(art254319):1–9CrossRef Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya JM (2012) Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Diseases 2012(art254319):1–9CrossRef
30.
Zurück zum Zitat Anaya JM, Castiblanco J, Rojas-Villarraga A et al (2012) The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allerg Immunol 43(3):256–64CrossRef Anaya JM, Castiblanco J, Rojas-Villarraga A et al (2012) The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allerg Immunol 43(3):256–64CrossRef
31.
Zurück zum Zitat Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK et al (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368:733–743PubMedCrossRef Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK et al (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368:733–743PubMedCrossRef
32.
Zurück zum Zitat Kuo CH, Kuo H-F, Huang C-H, Yang S-N, Lee M-S, Hung C-H (2013) Early life exposure to antibiotics and the risk of childhood allergic diseases: an update from the perspective of the hygiene hypothesis. J Microbiol Immunol Infect 2013(46):320–329CrossRef Kuo CH, Kuo H-F, Huang C-H, Yang S-N, Lee M-S, Hung C-H (2013) Early life exposure to antibiotics and the risk of childhood allergic diseases: an update from the perspective of the hygiene hypothesis. J Microbiol Immunol Infect 2013(46):320–329CrossRef
34.
Zurück zum Zitat Rook GAW (2012) Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol 42(1):5–15PubMedCrossRef Rook GAW (2012) Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol 42(1):5–15PubMedCrossRef
35.
Zurück zum Zitat Stiemsma LT, Reynolds LA, Turvey SE, Finlay BB (2015) The hygiene hypothesis: current perspectives and future therapies. ImmunoTargets and Therapy 4:143–157PubMedPubMedCentralCrossRef Stiemsma LT, Reynolds LA, Turvey SE, Finlay BB (2015) The hygiene hypothesis: current perspectives and future therapies. ImmunoTargets and Therapy 4:143–157PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Roduit C, Frei R, von Mutius E, Lauener R (2016) Environmental influences on the immune system. Ed: Esser C. Springer-Verllag Wien. 77-96 Roduit C, Frei R, von Mutius E, Lauener R (2016) Environmental influences on the immune system. Ed: Esser C. Springer-Verllag Wien. 77-96
38.
Zurück zum Zitat Van Riet E, Hartgers FC, Yazdanbakhsh M (2007) Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 212:475–490PubMedCrossRef Van Riet E, Hartgers FC, Yazdanbakhsh M (2007) Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 212:475–490PubMedCrossRef
39.
Zurück zum Zitat Taher TE, Muhammad HA, Bariller E, Flores-Borja F, Renaudineau Y, Isenberg DA, Mageed RA (2013) B-lymphocyte signalling abnormalities and lupus immunopathology. Int Rev Immunol 32(4):428–44PubMedCrossRef Taher TE, Muhammad HA, Bariller E, Flores-Borja F, Renaudineau Y, Isenberg DA, Mageed RA (2013) B-lymphocyte signalling abnormalities and lupus immunopathology. Int Rev Immunol 32(4):428–44PubMedCrossRef
40.
Zurück zum Zitat Mageed RA, Garaud S, Taher TE, Parikh K, Pers JO, Jamin C, Renaudineau Y, Youinou P (2012) CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte. Autoimmun Rev 11(11):795–8PubMedCrossRef Mageed RA, Garaud S, Taher TE, Parikh K, Pers JO, Jamin C, Renaudineau Y, Youinou P (2012) CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte. Autoimmun Rev 11(11):795–8PubMedCrossRef
41.
Zurück zum Zitat Mukherjee S, Brooks WH (2014) Stromal interaction molecules as important therapeutic targets in diseases with dysregulated calcium flux. Biochim Biophysica Acta 1843(10):2307–14CrossRef Mukherjee S, Brooks WH (2014) Stromal interaction molecules as important therapeutic targets in diseases with dysregulated calcium flux. Biochim Biophysica Acta 1843(10):2307–14CrossRef
42.
Zurück zum Zitat Kidd P (2003) Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8(3):223–46PubMed Kidd P (2003) Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8(3):223–46PubMed
43.
Zurück zum Zitat Marwaha AK, Leung NJ, McMurchy AN, Levings MK (2012) TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic? Front Immunol 3:129–34PubMedPubMedCentralCrossRef Marwaha AK, Leung NJ, McMurchy AN, Levings MK (2012) TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic? Front Immunol 3:129–34PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Burkett PR, zu Horste GM, Kuchroo VK (2015) Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J Clin Invest 125(6):2211–2219PubMedPubMedCentralCrossRef Burkett PR, zu Horste GM, Kuchroo VK (2015) Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J Clin Invest 125(6):2211–2219PubMedPubMedCentralCrossRef
45.
46.
Zurück zum Zitat Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathology 181:8–18CrossRef Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathology 181:8–18CrossRef
47.
Zurück zum Zitat Sharp A, Robinson D, Jacobs P (2000) Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genetics 107(4):343–9CrossRef Sharp A, Robinson D, Jacobs P (2000) Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genetics 107(4):343–9CrossRef
48.
Zurück zum Zitat Plengel RM, Stevenson RA, Lubs HA, Schwartz CE, Willard HF (2002) Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am J Hum Genetics 71(1):168–73CrossRef Plengel RM, Stevenson RA, Lubs HA, Schwartz CE, Willard HF (2002) Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am J Hum Genetics 71(1):168–73CrossRef
49.
Zurück zum Zitat Pegoraro E, Whitaker J, Mowery-Rushton P, Surti U, Lanasa M, Hoffman EP (1997) Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28. Am J Hum Genetics 61(1):160–70CrossRef Pegoraro E, Whitaker J, Mowery-Rushton P, Surti U, Lanasa M, Hoffman EP (1997) Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28. Am J Hum Genetics 61(1):160–70CrossRef
50.
Zurück zum Zitat Brix TH, Knudsen GPS, Kristiansen M et al (2005) High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metabol 90(11):5949–53CrossRef Brix TH, Knudsen GPS, Kristiansen M et al (2005) High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metabol 90(11):5949–53CrossRef
51.
Zurück zum Zitat Simmonds MJ, Kavvoura FK, Brand OJ et al (2014) Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis. J Clin Endocrin Metabol 99(1):E127–E131CrossRef Simmonds MJ, Kavvoura FK, Brand OJ et al (2014) Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis. J Clin Endocrin Metabol 99(1):E127–E131CrossRef
53.
Zurück zum Zitat Özbalkan Z, Baǧışlar S, Kiraz S et al (2005) Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52(5):1564–70PubMedCrossRef Özbalkan Z, Baǧışlar S, Kiraz S et al (2005) Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52(5):1564–70PubMedCrossRef
54.
Zurück zum Zitat Knudsen GPS, Harbo HF, Smestad C et al (2007) X chromosome inactivation in females with multiple sclerosis. Eur J Neurol 14(12):1392–6PubMedCrossRef Knudsen GPS, Harbo HF, Smestad C et al (2007) X chromosome inactivation in females with multiple sclerosis. Eur J Neurol 14(12):1392–6PubMedCrossRef
55.
Zurück zum Zitat Brooks WH (2010) X chromosome inactivation and autoimmunity. Clinic Rev Allerg Immunol 39:20–29CrossRef Brooks WH (2010) X chromosome inactivation and autoimmunity. Clinic Rev Allerg Immunol 39:20–29CrossRef
57.
Zurück zum Zitat Oldstone MBA (2014) Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases. Monoclonal antibodies in immunodiagnosis and immunotherapy 33:158–165PubMedPubMedCentralCrossRef Oldstone MBA (2014) Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases. Monoclonal antibodies in immunodiagnosis and immunotherapy 33:158–165PubMedPubMedCentralCrossRef
58.
59.
Zurück zum Zitat Sundar K, Jacques S, Gottlieb P, Villars R, Benito M-E, Taylor DK, Spatz LA (2004) Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmunity 23(2):127–140CrossRef Sundar K, Jacques S, Gottlieb P, Villars R, Benito M-E, Taylor DK, Spatz LA (2004) Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmunity 23(2):127–140CrossRef
60.
Zurück zum Zitat Cusick MF, Libbey JE, Fujinami RS (2012) Molecular mimicry as a mechanism of autoimmune disease. Clinic Rev Allerg Immunol 42:102–11CrossRef Cusick MF, Libbey JE, Fujinami RS (2012) Molecular mimicry as a mechanism of autoimmune disease. Clinic Rev Allerg Immunol 42:102–11CrossRef
61.
Zurück zum Zitat Vojdani A (2015) Molecular mimicry as a mechanism for food immune reactivities and autoimmunity. Alternative Therapies in Health and Medicine, suppl 121:34–45 Vojdani A (2015) Molecular mimicry as a mechanism for food immune reactivities and autoimmunity. Alternative Therapies in Health and Medicine, suppl 121:34–45
62.
Zurück zum Zitat Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD (1998) The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Reviews 164(1):63–72CrossRef Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD (1998) The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Reviews 164(1):63–72CrossRef
63.
Zurück zum Zitat Cornaby C, Gibbons L, Mayhew V et al (2015) B cell epitope spreading: mechanisms and contribution to autoimmune diseases. Immunol Lett 163(1):56–68PubMedCrossRef Cornaby C, Gibbons L, Mayhew V et al (2015) B cell epitope spreading: mechanisms and contribution to autoimmune diseases. Immunol Lett 163(1):56–68PubMedCrossRef
64.
Zurück zum Zitat Sokolove J, Bromberg R, Deane KD et al (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 7(5), e35296PubMedPubMedCentralCrossRef Sokolove J, Bromberg R, Deane KD et al (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 7(5), e35296PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Shoenfeld Y, Agmon-Levin N (2011) ‘ASIA’—autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmunity 36:4e8CrossRef Shoenfeld Y, Agmon-Levin N (2011) ‘ASIA’—autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmunity 36:4e8CrossRef
66.
Zurück zum Zitat Agmon-Levin N, Hughes GRV, Shoenfeld Y (2012) The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’. Lupus 21:118–20PubMedCrossRef Agmon-Levin N, Hughes GRV, Shoenfeld Y (2012) The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’. Lupus 21:118–20PubMedCrossRef
67.
Zurück zum Zitat Tervaert JWC, Kappel RM (2013) Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld’s syndrome). Immunol Res 56:293–98CrossRef Tervaert JWC, Kappel RM (2013) Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld’s syndrome). Immunol Res 56:293–98CrossRef
68.
Zurück zum Zitat Toubi E (2012) ASIA—Autoimmune Syndromes Induced by Adjuvants: rare, but worth considering. IMAJ 14:121–4PubMed Toubi E (2012) ASIA—Autoimmune Syndromes Induced by Adjuvants: rare, but worth considering. IMAJ 14:121–4PubMed
69.
Zurück zum Zitat Parks CG, Conrad K, Cooper GS (1999) Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 107(suppl 5):793–802PubMedPubMedCentralCrossRef Parks CG, Conrad K, Cooper GS (1999) Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 107(suppl 5):793–802PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Goren I, Segal G, Shoenfeld Y (2015) Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk? Clin Rheumatol 34:1661–6PubMedCrossRef Goren I, Segal G, Shoenfeld Y (2015) Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk? Clin Rheumatol 34:1661–6PubMedCrossRef
71.
Zurück zum Zitat Colafrancesco S, Perriconea C, Prioria R et al (2014) Sjögren’s syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). J Autoimmunity 51:10–16CrossRef Colafrancesco S, Perriconea C, Prioria R et al (2014) Sjögren’s syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). J Autoimmunity 51:10–16CrossRef
72.
Zurück zum Zitat Fasano A (2012) Leaky gut and autoimmune diseases. Clin Rev Allerg Immunol 42(1):71–8CrossRef Fasano A (2012) Leaky gut and autoimmune diseases. Clin Rev Allerg Immunol 42(1):71–8CrossRef
73.
Zurück zum Zitat Davis-Richardson AG, Triplett EW (2015) A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 58:1386–93PubMedPubMedCentralCrossRef Davis-Richardson AG, Triplett EW (2015) A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 58:1386–93PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Severance EG, Yolken RH, Eaton WW (2014) Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophrenia Research (in press, proofs available online). Severance EG, Yolken RH, Eaton WW (2014) Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophrenia Research (in press, proofs available online).
76.
Zurück zum Zitat D’Agostino L, Di Luccia A (2002) Polyamines interact with DNA as molecular aggregates. Eur J Biochem 269:4317–4325PubMedCrossRef D’Agostino L, Di Luccia A (2002) Polyamines interact with DNA as molecular aggregates. Eur J Biochem 269:4317–4325PubMedCrossRef
77.
Zurück zum Zitat D’Agostino L, Di Pietro M, Di Luccia A (2005) Nuclear aggregates of polyamines are supramolecular structures that play a crucial role in genomic DNA protection and conformation. FEBS J 272:3777–3787PubMedCrossRef D’Agostino L, Di Pietro M, Di Luccia A (2005) Nuclear aggregates of polyamines are supramolecular structures that play a crucial role in genomic DNA protection and conformation. FEBS J 272:3777–3787PubMedCrossRef
78.
Zurück zum Zitat Iacomino G, Picariello G, Sbrana F, Di Luccia A, Raiteri R, D’Agostino L (2011) DNA is wrapped by the nuclear aggregates of polyamines: the imaging evidence. Biomacromolecules 12:1178–1186PubMedCrossRef Iacomino G, Picariello G, Sbrana F, Di Luccia A, Raiteri R, D’Agostino L (2011) DNA is wrapped by the nuclear aggregates of polyamines: the imaging evidence. Biomacromolecules 12:1178–1186PubMedCrossRef
79.
Zurück zum Zitat Iacomino G, Picariello G, D’Agostino L (2012) DNA and nuclear aggregates of polyamines. Biochim Biophys Acta 1823:1745–1755PubMedCrossRef Iacomino G, Picariello G, D’Agostino L (2012) DNA and nuclear aggregates of polyamines. Biochim Biophys Acta 1823:1745–1755PubMedCrossRef
80.
Zurück zum Zitat Brooks WH (2012) Autoimmune diseases and polyamines. Clinic Rev Allerg Immunol 42:58–70CrossRef Brooks WH (2012) Autoimmune diseases and polyamines. Clinic Rev Allerg Immunol 42:58–70CrossRef
81.
Zurück zum Zitat Su KY, Pisetsky DS (2009) The role of extracellular DNA in autoimmunity in SLE. Scand J Immunol 70:175–83PubMedCrossRef Su KY, Pisetsky DS (2009) The role of extracellular DNA in autoimmunity in SLE. Scand J Immunol 70:175–83PubMedCrossRef
82.
Zurück zum Zitat Wagner AJ, Meyers C, Laimins LA, Hay N (1993) C-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ 4:879e83 Wagner AJ, Meyers C, Laimins LA, Hay N (1993) C-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ 4:879e83
83.
Zurück zum Zitat Lam YW, Trinkle-Mulcahy L (2015) New insights into nucleolar structure and function. F1000Prime Reports. 7:48. Lam YW, Trinkle-Mulcahy L (2015) New insights into nucleolar structure and function. F1000Prime Reports. 7:48.
85.
Zurück zum Zitat Rodriguez-Sanchez JL, Gelpi C, Juarez C, Hardin JA (1987) Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. J Immunol 139(8):2579–84PubMed Rodriguez-Sanchez JL, Gelpi C, Juarez C, Hardin JA (1987) Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. J Immunol 139(8):2579–84PubMed
86.
Zurück zum Zitat Zhang LF, Huynh KD, Lee JT (2007) Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. Cell 129:693–706PubMedCrossRef Zhang LF, Huynh KD, Lee JT (2007) Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. Cell 129:693–706PubMedCrossRef
87.
Zurück zum Zitat Hernandez-Verdun D, Roussel P, Thiry M, Sirri V, Lafontaine DLJ (2010) The nucleolus: structure/function relationship in RNA metabolism. WIREs RNA 1:415–31PubMedCrossRef Hernandez-Verdun D, Roussel P, Thiry M, Sirri V, Lafontaine DLJ (2010) The nucleolus: structure/function relationship in RNA metabolism. WIREs RNA 1:415–31PubMedCrossRef
88.
Zurück zum Zitat Whelly SM (1991) Role of polyamines in the regulation of RNA synthesis in uterine nucleoli. J Steroid Biochem Mol Biol 39:161–7PubMedCrossRef Whelly SM (1991) Role of polyamines in the regulation of RNA synthesis in uterine nucleoli. J Steroid Biochem Mol Biol 39:161–7PubMedCrossRef
89.
Zurück zum Zitat Igarashi K, Kashiwagi K (2010) Modulation of cellular function by polyamines. Intl J Biochem Cell Biol 42:39–51CrossRef Igarashi K, Kashiwagi K (2010) Modulation of cellular function by polyamines. Intl J Biochem Cell Biol 42:39–51CrossRef
90.
Zurück zum Zitat Shin M, Nakamuta H, Oda-Ueda N, Larsson LI, Fujiwara K (2008) Immunocytochemical demonstration of polyamines in nucleoli and nuclei. Histochem Cell Biol 129:659–65PubMedCrossRef Shin M, Nakamuta H, Oda-Ueda N, Larsson LI, Fujiwara K (2008) Immunocytochemical demonstration of polyamines in nucleoli and nuclei. Histochem Cell Biol 129:659–65PubMedCrossRef
91.
Zurück zum Zitat Jovine L, Djordjevic S, Rhodes D (2002) The crystal structure of yeast phenylalanine tRNA at 2.0 A resolution: cleavage by Mg(2+) in 15-year old crystals. J Mol Biol 301:401–14CrossRef Jovine L, Djordjevic S, Rhodes D (2002) The crystal structure of yeast phenylalanine tRNA at 2.0 A resolution: cleavage by Mg(2+) in 15-year old crystals. J Mol Biol 301:401–14CrossRef
93.
Zurück zum Zitat Bale S, Lopez MM, Makhatadze GI, Fang Q, Pegg AE, Ealick SE (2008) Structural basis for putrescine activation of human S-adenosylmethionine decarboxylase. Biochemistry 47:13404–13417PubMedPubMedCentralCrossRef Bale S, Lopez MM, Makhatadze GI, Fang Q, Pegg AE, Ealick SE (2008) Structural basis for putrescine activation of human S-adenosylmethionine decarboxylase. Biochemistry 47:13404–13417PubMedPubMedCentralCrossRef
94.
Zurück zum Zitat Neidhart M, Karouzakis E, Jüngel A, Gay RE, Gay S (2014) Inhibition of spermidine/spermine N1-acetyltransferase activity: a new therapeutic concept in rheumatoid arthritis. Arthritis Rheum 66(7):1723–33CrossRef Neidhart M, Karouzakis E, Jüngel A, Gay RE, Gay S (2014) Inhibition of spermidine/spermine N1-acetyltransferase activity: a new therapeutic concept in rheumatoid arthritis. Arthritis Rheum 66(7):1723–33CrossRef
95.
Zurück zum Zitat Karouzakis E, Gay RE, Gay S, Neidhart M (2012) Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 64:1809–1817PubMedCrossRef Karouzakis E, Gay RE, Gay S, Neidhart M (2012) Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 64:1809–1817PubMedCrossRef
96.
Zurück zum Zitat Bajaj BG, Murakami M, Cai Q et al (2008) Epstein–Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J Virol 82:4082–90PubMedPubMedCentralCrossRef Bajaj BG, Murakami M, Cai Q et al (2008) Epstein–Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J Virol 82:4082–90PubMedPubMedCentralCrossRef
97.
Zurück zum Zitat Bello-Fernandez C, Packham G, Cleveland JL (1993) The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A 90:7804–8PubMedPubMedCentralCrossRef Bello-Fernandez C, Packham G, Cleveland JL (1993) The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A 90:7804–8PubMedPubMedCentralCrossRef
99.
Zurück zum Zitat Nilsson JA, Keller UB, Baudino TA et al (2005) Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell 7:433–44PubMedCrossRef Nilsson JA, Keller UB, Baudino TA et al (2005) Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell 7:433–44PubMedCrossRef
100.
Zurück zum Zitat Gfeller E, Stern DN, Russell DH, Levy CC, Taylor RL (1972) Ultrastructural changes in vitro of rat liver nucleoli in response to polyamines. Z Zellforsch Mikrosk Anat 129(4):447–54PubMedCrossRef Gfeller E, Stern DN, Russell DH, Levy CC, Taylor RL (1972) Ultrastructural changes in vitro of rat liver nucleoli in response to polyamines. Z Zellforsch Mikrosk Anat 129(4):447–54PubMedCrossRef
101.
Zurück zum Zitat Gomez-Roman N, Grandori C, Eisenman RN, White RJ (2003) Direct activation of RNA polymerase III transcription by c-Myc. Nature 421:290–4PubMedCrossRef Gomez-Roman N, Grandori C, Eisenman RN, White RJ (2003) Direct activation of RNA polymerase III transcription by c-Myc. Nature 421:290–4PubMedCrossRef
102.
Zurück zum Zitat Felton-Edkins ZA, Kondrashov A, Karali D et al (2006) Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. J Biol Chem 281:33871–80PubMedCrossRef Felton-Edkins ZA, Kondrashov A, Karali D et al (2006) Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. J Biol Chem 281:33871–80PubMedCrossRef
103.
Zurück zum Zitat Toussirot E, Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheum 22(5):883–96CrossRef Toussirot E, Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheum 22(5):883–96CrossRef
104.
Zurück zum Zitat Sharma V, Tekwani BL, Saxena JK, Gupta S, Katiyar JC, Chatterjee RK et al (1991) Polyamine metabolism in helminth parasites. ExpParasitol 72:15–23 Sharma V, Tekwani BL, Saxena JK, Gupta S, Katiyar JC, Chatterjee RK et al (1991) Polyamine metabolism in helminth parasites. ExpParasitol 72:15–23
105.
Zurück zum Zitat Finlay CM, Stefanska AM, Walsh KP, Kelly PJ, Boon L, Lavelle EC, Walsh PT, Mills KH (2016) Helminth products protect against autoimmunity via innate type 2 cytokines IL-5 and IL-33, which promote eosinophilia. J Immunol 196(2):703–14PubMedCrossRef Finlay CM, Stefanska AM, Walsh KP, Kelly PJ, Boon L, Lavelle EC, Walsh PT, Mills KH (2016) Helminth products protect against autoimmunity via innate type 2 cytokines IL-5 and IL-33, which promote eosinophilia. J Immunol 196(2):703–14PubMedCrossRef
107.
Zurück zum Zitat Ross MT, Bentley DR, Tyler-Smith C (2006) The sequences of the human sex chromosomes. Curr Op Genetics & Develop 2006(16):213–18CrossRef Ross MT, Bentley DR, Tyler-Smith C (2006) The sequences of the human sex chromosomes. Curr Op Genetics & Develop 2006(16):213–18CrossRef
108.
Zurück zum Zitat Barr ML, Carr DH (1962) Correlations between sex chromatin and sex chromosomes. Acta Cytol 6:34–45PubMed Barr ML, Carr DH (1962) Correlations between sex chromatin and sex chromosomes. Acta Cytol 6:34–45PubMed
109.
Zurück zum Zitat Blaschke JR, Rappold G (2006) The pseudoautosomal regions, SHOX and disease. Curr Op Genetics Dev 16:233–239CrossRef Blaschke JR, Rappold G (2006) The pseudoautosomal regions, SHOX and disease. Curr Op Genetics Dev 16:233–239CrossRef
110.
Zurück zum Zitat Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400–4PubMedCrossRef Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400–4PubMedCrossRef
111.
Zurück zum Zitat Carrel L, Cottle AA, Goglin KC, Willard HF (1999) A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci U S A 96:14440–4PubMedPubMedCentralCrossRef Carrel L, Cottle AA, Goglin KC, Willard HF (1999) A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci U S A 96:14440–4PubMedPubMedCentralCrossRef
112.
Zurück zum Zitat Cotton AM, Ge B, Light N, Pastinen T, Brown CJ (2013) Analysis of expressed SNPs identifies variable extents of expression from the human inactive X chromosome. Genome Biol 14:R122PubMedPubMedCentralCrossRef Cotton AM, Ge B, Light N, Pastinen T, Brown CJ (2013) Analysis of expressed SNPs identifies variable extents of expression from the human inactive X chromosome. Genome Biol 14:R122PubMedPubMedCentralCrossRef
113.
Zurück zum Zitat Higashi K, Yoshida M, Igarashi A et al (2009) Intense correlation between protein-conjugated acrolein and primary Sjӧgren’s syndrome. Clin Chim Acta 411:359–63PubMedCrossRef Higashi K, Yoshida M, Igarashi A et al (2009) Intense correlation between protein-conjugated acrolein and primary Sjӧgren’s syndrome. Clin Chim Acta 411:359–63PubMedCrossRef
114.
Zurück zum Zitat Agostinelli E (2014) Polyamines and transglutaminases: biological, clinical and biotechnological perspectives. Amino Acids 46:475–85PubMedCrossRef Agostinelli E (2014) Polyamines and transglutaminases: biological, clinical and biotechnological perspectives. Amino Acids 46:475–85PubMedCrossRef
115.
Zurück zum Zitat WangY LM, Stadler S et al (2009) Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 184:205–13CrossRef WangY LM, Stadler S et al (2009) Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 184:205–13CrossRef
116.
Zurück zum Zitat Arita K, Hashimoto H, Shimizu T et al (2004) Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 11:777–783PubMedCrossRef Arita K, Hashimoto H, Shimizu T et al (2004) Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 11:777–783PubMedCrossRef
117.
Zurück zum Zitat Slade DJ, Fang P, Dreyton CJ et al (2015) Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design. ACS Chem Biol 10:1043–53PubMedPubMedCentralCrossRef Slade DJ, Fang P, Dreyton CJ et al (2015) Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design. ACS Chem Biol 10:1043–53PubMedPubMedCentralCrossRef
118.
Zurück zum Zitat Zhu H, Luo H, Yan M, Zuo X, Li QZ (2015) Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus. Genomics Proteomics Bioinformatics 13:210–8PubMedPubMedCentralCrossRef Zhu H, Luo H, Yan M, Zuo X, Li QZ (2015) Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus. Genomics Proteomics Bioinformatics 13:210–8PubMedPubMedCentralCrossRef
119.
Zurück zum Zitat Yaniv G, Twig G, Shor DB et al (2015) A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmunity Rev 14:75–9CrossRef Yaniv G, Twig G, Shor DB et al (2015) A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmunity Rev 14:75–9CrossRef
120.
Zurück zum Zitat Reichlin M (1991) Systemic lupus erythematosus. In: Bigazzi PE (ed) Systemic Autoimmunity. Marcel Dekker Inc., New York, pp 163–200 Reichlin M (1991) Systemic lupus erythematosus. In: Bigazzi PE (ed) Systemic Autoimmunity. Marcel Dekker Inc., New York, pp 163–200
121.
Zurück zum Zitat Lartigue A, Drouot L, Jouen F et al (2005) Association between anti-nucleophosmin and anti-cardiolipin antibodies in (NZW × BXSB)F1 mice and human systemic lupus erythematosus. Arthritis Res Therapy 57:R1394CrossRef Lartigue A, Drouot L, Jouen F et al (2005) Association between anti-nucleophosmin and anti-cardiolipin antibodies in (NZW × BXSB)F1 mice and human systemic lupus erythematosus. Arthritis Res Therapy 57:R1394CrossRef
122.
Zurück zum Zitat Brown CJ, Greally JM (2003) A stain upon the silence: genes escaping X inactivation. Trends 810 Genet 19:432–38CrossRef Brown CJ, Greally JM (2003) A stain upon the silence: genes escaping X inactivation. Trends 810 Genet 19:432–38CrossRef
123.
Zurück zum Zitat Kim C, Rubin CM, Schmid CW (2001) Genome-wide chromatin remodeling modulates the Alu 919 heat shock response. Gene 276:127–33PubMedCrossRef Kim C, Rubin CM, Schmid CW (2001) Genome-wide chromatin remodeling modulates the Alu 919 heat shock response. Gene 276:127–33PubMedCrossRef
124.
125.
Zurück zum Zitat Cooney CM, Bruner GR, Aberle T et al (2009) 46, X, del(X)(q13) Turner’s syndrome female with systemic lupus erythematosus in a pedigree multiplex for SLE. Genes Immun 10:478–81PubMedPubMedCentralCrossRef Cooney CM, Bruner GR, Aberle T et al (2009) 46, X, del(X)(q13) Turner’s syndrome female with systemic lupus erythematosus in a pedigree multiplex for SLE. Genes Immun 10:478–81PubMedPubMedCentralCrossRef
126.
Zurück zum Zitat Slae M, Heshin-Bekenstein M, Sinckes A, Heimer G, Engelhard D, Eisenstein EM (2014) Female polysomy-X and systemic lupus erythematosus. Sem Arthritis Rheum 43(4):508–512CrossRef Slae M, Heshin-Bekenstein M, Sinckes A, Heimer G, Engelhard D, Eisenstein EM (2014) Female polysomy-X and systemic lupus erythematosus. Sem Arthritis Rheum 43(4):508–512CrossRef
127.
Zurück zum Zitat Rook GAW (2009) Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunol 126(1):3–11CrossRef Rook GAW (2009) Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunol 126(1):3–11CrossRef
Metadaten
Titel
A Review of Autoimmune Disease Hypotheses with Introduction of the “Nucleolus” Hypothesis
verfasst von
Wesley H. Brooks
Publikationsdatum
21.06.2016
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2017
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-016-8567-2

Weitere Artikel der Ausgabe 3/2017

Clinical Reviews in Allergy & Immunology 3/2017 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.